AU2003299710A1 - Use of ghrelin for treating malnutrition in gastrectomized individuals - Google Patents
Use of ghrelin for treating malnutrition in gastrectomized individualsInfo
- Publication number
- AU2003299710A1 AU2003299710A1 AU2003299710A AU2003299710A AU2003299710A1 AU 2003299710 A1 AU2003299710 A1 AU 2003299710A1 AU 2003299710 A AU2003299710 A AU 2003299710A AU 2003299710 A AU2003299710 A AU 2003299710A AU 2003299710 A1 AU2003299710 A1 AU 2003299710A1
- Authority
- AU
- Australia
- Prior art keywords
- gastrectomized
- ghrelin
- body weight
- individuals
- gen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000012004 Ghrelin Human genes 0.000 title abstract 3
- 101800001586 Ghrelin Proteins 0.000 title abstract 3
- GNKDKYIHGQKHHM-RJKLHVOGSA-N ghrelin Chemical compound C([C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CN)COC(=O)CCCCCCC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CC=CC=C1 GNKDKYIHGQKHHM-RJKLHVOGSA-N 0.000 title abstract 3
- 208000002720 Malnutrition Diseases 0.000 title 1
- 230000001071 malnutrition Effects 0.000 title 1
- 235000000824 malnutrition Nutrition 0.000 title 1
- 208000015380 nutritional deficiency disease Diseases 0.000 title 1
- 241000700159 Rattus Species 0.000 abstract 2
- 230000037396 body weight Effects 0.000 abstract 2
- 208000030814 Eating disease Diseases 0.000 abstract 1
- 208000019454 Feeding and Eating disease Diseases 0.000 abstract 1
- 208000015580 Increased body weight Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 210000000577 adipose tissue Anatomy 0.000 abstract 1
- 230000001539 anorectic effect Effects 0.000 abstract 1
- 206010061428 decreased appetite Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 230000000580 secretagogue effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Marine Sciences & Fisheries (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Gas Separation By Absorption (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20020022705 EP1407779A1 (en) | 2002-10-10 | 2002-10-10 | Use of ghrelin for treating low body weight and body fat in gastrectomized individuals |
| EP02022705.4 | 2002-10-10 | ||
| PCT/DK2003/000679 WO2004032952A1 (en) | 2002-10-10 | 2003-10-09 | Use of ghrelin for treating malnutrition in gastrectomized individuals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003299710A1 true AU2003299710A1 (en) | 2004-05-04 |
Family
ID=32010955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003299710A Abandoned AU2003299710A1 (en) | 2002-10-10 | 2003-10-09 | Use of ghrelin for treating malnutrition in gastrectomized individuals |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7592305B2 (zh) |
| EP (2) | EP1407779A1 (zh) |
| JP (1) | JP4177224B2 (zh) |
| KR (1) | KR20050057650A (zh) |
| CN (1) | CN1723035A (zh) |
| AT (1) | ATE324904T1 (zh) |
| AU (1) | AU2003299710A1 (zh) |
| DE (1) | DE60305055T2 (zh) |
| WO (1) | WO2004032952A1 (zh) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1688696A (zh) * | 2002-09-18 | 2005-10-26 | 蒙特利尔大学医疗中心 | Ghrh类似物 |
| USRE42624E1 (en) | 2003-06-18 | 2011-08-16 | Tranzyme Pharma Inc. | Methods of using macrocyclic modulators of the ghrelin receptor |
| WO2005097174A2 (en) * | 2004-04-07 | 2005-10-20 | Gastrotech Pharma A/S | Uses of a combination of ghrelin and somatotropin for the treatment of cachexia |
| JP2007532495A (ja) * | 2004-04-07 | 2007-11-15 | ガストロテック・ファルマ・アクティーゼルスカブ | グレリン欠乏を治療するための分泌促進薬の使用 |
| KR20070050871A (ko) * | 2004-05-11 | 2007-05-16 | 더 거번먼트 오브 더 유나이티드 스테이츠 오브 어메리카 애즈 레프리젠티드 바이 더 세크러터리 오브 더 디파트먼트 오브 헬쓰 앤드 휴먼 써비시즈 | 그렐린을 사용하여 전염증성 사이토킨 발현을 억제하는방법 |
| JP4951344B2 (ja) * | 2004-08-24 | 2012-06-13 | 第一三共株式会社 | 生理活性ペプチド液状製剤 |
| US20080300180A1 (en) * | 2004-11-30 | 2008-12-04 | Gastrotech Pharma A/S | Growth Hormone Secretagogue Receptor 1A Ligands |
| EP2046376B1 (en) * | 2006-08-01 | 2018-08-01 | The Scripps Research Institute | Vaccines and methods for controlling adiposity |
| CA2677045C (en) | 2007-01-31 | 2016-10-18 | Dana-Farber Cancer Institute, Inc. | Stabilized p53 peptides and uses thereof |
| AU2008216906A1 (en) * | 2007-02-14 | 2008-08-21 | Karolinska Innovations Ab | Compositions for increasing body weight, use and methods |
| AU2008232709C1 (en) | 2007-03-28 | 2015-01-15 | President And Fellows Of Harvard College | Stitched polypeptides |
| US8324151B2 (en) * | 2007-11-20 | 2012-12-04 | The Feinstein Institute For Medical Research | Treatment of sepsis and septic shock using ghrelin and growth hormone |
| US8013015B2 (en) * | 2008-10-02 | 2011-09-06 | Board Of Regents, The University Of Texas System | Small molecule inhibitors of ghrelin O-acyltransferase |
| ES2599168T3 (es) * | 2010-01-15 | 2017-01-31 | University Of Miyazaki | Grelina para promover la recuperación de un animal en tratamiento médico |
| SI2603600T1 (sl) | 2010-08-13 | 2019-04-30 | Aileron Therapeutics, Inc. | Peptidomimetični makrocikli |
| AU2012214827B2 (en) * | 2011-02-09 | 2016-06-09 | The Scripps Research Institute | Ghrelin mimetic polypeptide hapten immunoconjugates having improved solubility and immunogenicity and methods of use thereof |
| TWI643868B (zh) | 2011-10-18 | 2018-12-11 | 艾利倫治療公司 | 擬肽巨環化合物 |
| US8987414B2 (en) | 2012-02-15 | 2015-03-24 | Aileron Therapeutics, Inc. | Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles |
| KR102112373B1 (ko) | 2012-02-15 | 2020-05-18 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티드모방체 마크로사이클 |
| AU2013337388B2 (en) | 2012-11-01 | 2018-08-02 | Aileron Therapeutics, Inc. | Disubstituted amino acids and methods of preparation and use thereof |
| WO2015048091A1 (en) * | 2013-09-24 | 2015-04-02 | The Board Of Regents Of The University Of Texas System | Orexin-control of bone formation and loss |
| WO2016049359A1 (en) | 2014-09-24 | 2016-03-31 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
| MX2017011834A (es) | 2015-03-20 | 2018-04-11 | Aileron Therapeutics Inc | Macrociclos peptidomimeticos y usos de los mismos. |
| WO2023161226A1 (en) * | 2022-02-22 | 2023-08-31 | Pephexia Therapeutics Aps | Ghrelin agonists with improved potency |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2323159T3 (es) | 1995-12-22 | 2009-07-07 | Novo Nordisk A/S | Compuestos con propiedades de liberacion de la hormona del crecimiento. |
| CN1291994A (zh) | 1998-03-03 | 2001-04-18 | 诺沃挪第克公司 | 新的(2e)－5－氨基－5－甲基已－2－烯酸n－甲基－n－((1r)－1－(n－甲基－n－(1r)－1－(甲基氨基甲酰基)－2－苯2基氨基甲酰基－2－(2－萘基)2基酰胺的盐 |
| PL194560B1 (pl) | 1998-05-11 | 2007-06-29 | Novo Nordisk As | Związki o właściwościach uwalniania hormonu wzrostu, kompozycja farmaceutyczna zawierająca te związki oraz ich zastosowanie |
| JP4481502B2 (ja) | 1998-11-03 | 2010-06-16 | サファイア セラピューティクス，インコーポレイティド | 成長ホルモン放出特性を有する化合物 |
| DK1197496T3 (da) * | 1999-07-23 | 2007-10-22 | Kenji Kangawa | Hidtil ukendte peptider |
| AU2001228325A1 (en) * | 2000-02-01 | 2001-08-14 | Novo-Nordisk A/S | Use of compounds for the regulation of food intake |
| US7244701B2 (en) | 2000-06-16 | 2007-07-17 | Zealand Phama A/S | Diuretic peptide conjugate |
-
2002
- 2002-10-10 EP EP20020022705 patent/EP1407779A1/en not_active Withdrawn
-
2003
- 2003-10-09 AT AT03756447T patent/ATE324904T1/de not_active IP Right Cessation
- 2003-10-09 KR KR1020057006275A patent/KR20050057650A/ko not_active Application Discontinuation
- 2003-10-09 DE DE60305055T patent/DE60305055T2/de not_active Expired - Lifetime
- 2003-10-09 AU AU2003299710A patent/AU2003299710A1/en not_active Abandoned
- 2003-10-09 WO PCT/DK2003/000679 patent/WO2004032952A1/en not_active Application Discontinuation
- 2003-10-09 US US10/530,866 patent/US7592305B2/en not_active Expired - Fee Related
- 2003-10-09 CN CNA2003801057083A patent/CN1723035A/zh active Pending
- 2003-10-09 EP EP03756447A patent/EP1553969B1/en not_active Expired - Lifetime
- 2003-10-10 JP JP2003352592A patent/JP4177224B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004277402A (ja) | 2004-10-07 |
| US7592305B2 (en) | 2009-09-22 |
| CN1723035A (zh) | 2006-01-18 |
| EP1407779A1 (en) | 2004-04-14 |
| EP1553969A1 (en) | 2005-07-20 |
| JP4177224B2 (ja) | 2008-11-05 |
| DE60305055D1 (de) | 2006-06-08 |
| ATE324904T1 (de) | 2006-06-15 |
| US20060217296A1 (en) | 2006-09-28 |
| EP1553969B1 (en) | 2006-05-03 |
| KR20050057650A (ko) | 2005-06-16 |
| DE60305055T2 (de) | 2006-12-07 |
| WO2004032952A1 (en) | 2004-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003299710A1 (en) | Use of ghrelin for treating malnutrition in gastrectomized individuals | |
| WO2003068128A3 (de) | Massagegerät mit vorratsbehälter und einstelleinrichtung zur einstellung eines massagekennwerts | |
| AU2003249356A1 (en) | Safe and effective nutritional supplement formulatins and associated regimens adapted to prevent and/or treat targeted diseases or medical or health conditions, and related methods | |
| WO2001013906A3 (en) | Compositions including modafinil for treatment of eating disorders and for appetite stimulation | |
| WO2002060410A3 (en) | Methods for sustained release local delivery of drugs for ablation of unwanted tissue | |
| SI1677806T1 (sl) | Postopki za zdravljenje akutnega in s preobremenitvijo povzročenega zvina in natega z uporabo hialuronske kisline | |
| AU2003207417A1 (en) | Use of tryptophan rich peptides | |
| TW200501934A (en) | Therapeutic causing contraction of mucosal tissue, method of treating diseases relating to mucosal tissues, injector and therapeutic set | |
| HUP0202730A2 (hu) | Eljárás friss hús felületének kezelésére | |
| WO2000071075A8 (en) | Body treatment product | |
| WO2004056768A3 (en) | Use of substituted 2,5-diamidoindoles for the treatment of urological diseases | |
| AU2003283227A8 (en) | Method and means for the treatment of vascular and cardiac diseases | |
| WO2003034998A3 (en) | Composition and method for treating erectile dysfunction and reducing fibrosis in erectile tissue of the human penis | |
| 赵坚新 et al. | Treatment of infantile morbid night crying by acupuncture at Zhongchong point in 100 cases | |
| AU1564500A (en) | Method for obtaining and using a combination of a purine and a nitrogen monoxidedonor for preventing or treating sexual dysfunction | |
| ATE454397T1 (de) | Den blutzuckerspiegel bei diabetes mellitus regulierendes tetrapeptid | |
| WO2000078328A3 (de) | VERWENDUNG VON WACHSTUMSHORMON (hGH) ZUR THERAPIE SEXUELLER FUNKTIONSSTÖRUNGEN | |
| WO2003097690A3 (en) | Pth derivatives resistant to skin proteases | |
| Gilden | No attrition in research on wasting therapies | |
| 陈邦国 | OBSERVATI ON ON THE THERAPEUTIC EFFECT OF ACUPUNCTURE IN TREATMENT OF 68 CASES OFINSUFFICIENT BLOODSUPPLY OF CEREBRAL ARTERIES | |
| CN1090482C (zh) | 一种人体肌肤按摩油 | |
| 马天伟 | 43 CASES OF POSTOPERATIVE GASTROINTESTINAL DYSFUNCTION TREATED WITH ACUPUNCTURE PLUS AURICULAR-PLASTER THERAPY | |
| 夏晓菊 | OBSERVATION ON THE THERAPEUTIC EFFECTS OF 282 CASES WITH PAIN TREATED BY ACUPUNCTURE AT XI POINTS | |
| 郭非 et al. | Comprehensive rehabilitation of closed injury of brain | |
| 余晓阳 et al. | Acupuncture treatment for 87 cases of facial paralysis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |